These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 7371530)

  • 1. [Spironolactone in essential hypertension associated with abnormal aldosterone regulation and in Conn's syndrome (author's transl)].
    Wambach G; Helber A; Bönner G; Hummerich W; Meurer KA; Kaufmann W
    Dtsch Med Wochenschr; 1980 May; 105(18):647-51. PubMed ID: 7371530
    [No Abstract]   [Full Text] [Related]  

  • 2. [An observation of Conn's syndrome. Clinical and biological study].
    Tourniaire J; Revol A; Maret G; Blanc-Brunat N
    Rev Fr Endocrinol Clin; 1968; 9(4):333-50. PubMed ID: 4302797
    [No Abstract]   [Full Text] [Related]  

  • 3. [A description of a case of Conn's syndrome (author's transl)].
    Martin PL; Dallocchio M; Fourcade JP; Clémenty J; Coqueran J; Choussat A; Bricaud H
    J Radiol Electrol Med Nucl; 1974 May; 55(5):419-22. PubMed ID: 4408421
    [No Abstract]   [Full Text] [Related]  

  • 4. In vitro responses of aldosterone-producing adenomas to angiotensin II and ACTH after treatment with spironolactone before adrenalectomy.
    Wisgerhof M
    J Lab Clin Med; 1984 Aug; 104(2):160-5. PubMed ID: 6086794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of essential arterial hypertension with spironolactone: its value in the detection of primary hyperaldosteronism and prediction of its efficacy].
    Fournier A; Nakache JP; Salmon D; Kazandjian M; Baulon A; Legrand JC; Menard J; Lagrue G
    J Urol Nephrol (Paris); 1972 Dec; 78(12):1023-7. PubMed ID: 4661188
    [No Abstract]   [Full Text] [Related]  

  • 6. Twenty-four year spironolactone therapy in an aged patient with aldosterone-producing adenoma.
    Takeda R; Yamazaki T; Ito Y; Koshida H; Morise T; Miyamori I; Hashimoto T; Morimoto S
    Acta Endocrinol (Copenh); 1992 Feb; 126(2):186-90. PubMed ID: 1311894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma renin activity in the diagnosis of primary aldosteronism: failure to distinguish primary aldosteronism from essential hypertension.
    Jose A; Kaplan NM
    Arch Intern Med; 1969 Feb; 123(2):141-6. PubMed ID: 5812600
    [No Abstract]   [Full Text] [Related]  

  • 8. The spironolactone, amiloride, losartan, and thiazide (SALT) double-blind crossover trial in patients with low-renin hypertension and elevated aldosterone-renin ratio.
    Hood SJ; Taylor KP; Ashby MJ; Brown MJ
    Circulation; 2007 Jul; 116(3):268-75. PubMed ID: 17606839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Control of plasma aldosterone in a patient with Conn's syndrome before and during spironolactone medication.
    Vetter H; Vetter W
    Klin Wochenschr; 1975 Apr; 53(8):391-3. PubMed ID: 211313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormal regulation of aldosterone in hypertension.
    Luetscher JA; Ganguly A; Melada GA; Dowdy AJ
    Adv Intern Med; 1975; 20():183-96. PubMed ID: 163569
    [No Abstract]   [Full Text] [Related]  

  • 11. Normokalemic hyperaldosteronism in patients with resistant hypertension.
    Benchetrit S; Bernheim J; Podjarny E
    Isr Med Assoc J; 2002 Jan; 4(1):17-20. PubMed ID: 11802302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary aldosteronism -- screening, diagnosis and therapy.
    Horký K; Gregorová I; Vancura J; Silinková-Málková E; Hradec E
    Cor Vasa; 1981; 23(4):265-79. PubMed ID: 7028394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spironolactone bodies in an adrenal adenoma.
    Shrago SS; Waisman J; Cooper PH
    Arch Pathol; 1975 Aug; 99(8):416-20. PubMed ID: 167703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Primary hyperaldosteronism].
    Plouin PF; Massien-Simon C
    Rev Prat; 1998 Apr; 48(7):749-53. PubMed ID: 11767370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced aldosterone secretion during spironolactone treatment in primary aldosteronism: report of a case.
    Sundsfjord JA; Marton P; Jorgensen H; Aakvaag A
    J Clin Endocrinol Metab; 1974 Oct; 39(4):734-9. PubMed ID: 4370321
    [No Abstract]   [Full Text] [Related]  

  • 16. Combined captopril and spironolactone treatment in Conn's syndrome with renal impairment and refractory hypertension.
    Atkinson AB; Brown JJ; Davies DL; Lever AF; Robertson JI
    Clin Endocrinol (Oxf); 1981 Jan; 14(1):105-8. PubMed ID: 7014043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Biochemical detection of Conn's adenoma: definition of criteria and reference values].
    Gosse P; Guiheneuf-Tobie C; Lasserre R; Minifie C; Lemetayer P; Clementy J
    Arch Mal Coeur Vaiss; 2005 Mar; 98(3):181-5. PubMed ID: 15816319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of the plasma renin activity and urinary aldosterone excretion in patients with essential hypertension treated with spironolactone. Note II].
    Bompiani GD; Scaduto P; Galluzzo A; Donatelli M; Morici ML; Mangano MT; Messina L
    Minerva Cardioangiol; 1976 May; 24(5):352-9. PubMed ID: 1012481
    [No Abstract]   [Full Text] [Related]  

  • 19. [Plasma aldosterone and electrolytes in primary and secondard aldosteronism (author's transl)].
    Albert JP; Wronski R; Jentzen F; Hartmann F
    Med Klin; 1979 Sep; 74(37):1315-9. PubMed ID: 492054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Rectal electrical potential difference and plasma aldosterone in hyperaldosteronism and low-, normal- and high-renin hypertension].
    Skrabal F; Mauser R
    Wien Klin Wochenschr; 1976 Dec; 88(23):777-81. PubMed ID: 1014711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.